Ollie's SVP/CIO converts 3,159 options to shares and sells under 10b5-1

Rhea-AI Filing Summary

Ollie's Bargain Outlet Holdings, Inc. (OLLI) reported insider transactions by SVP & CIO Larry Kraus on 10/06/2025. The filing shows exercise of 3,159 employee stock options (aggregate of grants with strike prices of $43.21, $57.98, and $86.03) and contemporaneous sales of the same 3,159 shares under a Rule 10b5-1 plan adopted on 07/07/2025. Proceeds from the sales were reported at weighted average prices in the range near $131 per share, and the reporting person’s beneficial ownership following the transactions is shown as 3,679 shares held directly. The transactions were executed pursuant to a written trading plan and were reported by an attorney-in-fact on 10/08/2025.

Positive

• Transactions executed under a Rule 10b5-1 plan adopted on 07/07/2025, indicating pre-planned timing
• Exercised options converted to shares (3,159 shares), reflecting realization of compensation rather than new grant issuance
• Filing discloses vesting schedules for grants through 03/23/2027, providing transparency on future option vesting

Negative

• Insider sold 3,159 shares, reducing immediate direct economic exposure to the company's stock
• Sales occurred at weighted average prices near $131, which may indicate significant monetization at current market levels

Insights

Corporate Governance Analyst

TL;DR: Insider exercised vested options and sold the resulting shares under a 10b5-1 plan on 10/06/2025.

The reporting person exercised 3,159 stock options across three grants with exercise prices of $43.21, $57.98, and $86.03, and sold the same number of shares under a Rule 10b5-1 plan adopted on 07/07/2025. This pattern—exercise then sale via an approved plan—is a common mechanism for monetizing vested equity while aiming to mitigate insider trading risk.

Key dependencies and near-term items to watch include any future scheduled vesting (remaining option tranches noted in the filing) and whether additional 10b5-1 plans are adopted or amended; the filing discloses vesting schedules with installments through 03/25/2026 for certain grants.

Compensation & Equity Analyst

TL;DR: The transactions convert vested option value into cash at weighted-average sale prices near $131 per share.

The exercised options converted into 3,159 common shares and were immediately sold at weighted average prices reported in the filing (ranges cited around $130.51–$131.50). The filing also details historical grant sizes and vesting: grants from 03/22/2021, 03/25/2022, and 03/23/2023 with staggered 25% annual vesting.

Monitor the remaining unvested/vested option counts and the reporting person’s post-transaction direct ownership of 3,679 shares to assess future dilution and potential future sales when further tranches vest (notably through 03/23/2027 for some grants).

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kraus Larry

(Last) (First) (Middle)

C/O OLLIE'S BARGAIN OUTLET HOLDINGS, INC

6295 ALLENTOWN BLVD., SUITE 1

(Street)

HARRISBURG PA 17112

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ollie's Bargain Outlet Holdings, Inc. [ OLLI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, CIO

3. Date of Earliest Transaction (Month/Day/Year)
10/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.001 per share	10/06/2025		M(1)		2,559	A	$43.21	6,238	D
Common Stock, par value $0.001 per share	10/06/2025		S(1)		2,559	D	$131.55(2)	3,679	D
Common Stock, par value $0.001 per share	10/06/2025		M(1)		500	A	$57.98	4,179	D
Common Stock, par value $0.001 per share	10/06/2025		S(1)		500	D	$131.02(3)	3,679	D
Common Stock, par value $0.001 per share	10/06/2025		M(1)		100	A	$86.03	3,779	D
Common Stock, par value $0.001 per share	10/06/2025		S(1)		100	D	$131.4(4)	3,679	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$43.21	10/06/2025		M(1)			2,559	(5)	03/25/2032	Common Stock	2,559	$0	2,559	D
Employee Stock Option (right to buy)	$57.98	10/06/2025		M(1)			500	(6)	03/23/2033	Common Stock	500	$0	6,366	D
Employee Stock Option (right to buy)	$86.03	10/06/2025		M(1)			100	(7)	03/22/2031	Common Stock	100	$0	4,534	D

Explanation of Responses:

1. Transactions made pursuant to an agreement adopted on July 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

2. The price reported in column 4 is the price at which these shares were sold in a single transaction.

3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.51-131.44, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.27-131.50, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

5. Options vest and become exercisable in 25% installments on each anniversary date of the grant, March 25, 2022, subject to continued service through each applicable vesting date. The reporting person was granted 10,236 options, of which 2,559 vested on March 25, 2023; 2,559 vested on March 25, 2024; 2,559 vested on March 25, 2025; and 2,559 vest on March 25, 2026.

6. Options vest and become exercisable in 25% installments on each anniversary date of the grant, March 23, 2023, subject to continued service through each applicable vesting date. The reporting person was granted 6,866 options, of which 1,717 vested on March 23, 2024; 1,716 vested on March 23, 2025; 1,717 vest on March 23, 2026; and 1,716 vest on March 23, 2027.

7. Options vest and become exercisable in 25% installments on each anniversary date of the grant, March 22, 2021, subject to continued service through each applicable vesting date. The reporting person was granted 4,634 options, and the options vested in their entirely on March 22, 2025.

Remarks:

	/s/ James J. Comitale as Attorney-In-Fact	10/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did OLLI insider Larry Kraus do on 10/06/2025?

On 10/06/2025, Larry Kraus exercised 3,159 options and sold the resulting 3,159 shares under a Rule 10b5-1 plan.

How many shares does the reporting person own after these transactions (OLLI)?

The filing shows 3,679 shares beneficially owned directly following the reported transactions.

What were the exercise prices for the options exercised by the OLLI insider?

The exercised options had strike prices of $43.21, $57.98, and $86.03.

At what prices were the shares sold in the 10b5-1 transactions?

Sales were reported at weighted average prices around $131, with specific ranges noted between $130.51–$131.50 in the filing.

When was the 10b5-1 plan adopted for these trades?

The filing states the trading agreement was adopted on 07/07/2025 in accordance with Rule 10b5-1.